The initial success of Viagra undeniably revolutionized the medication landscape, but placing funds in companies heavily reliant on off-patent versions presents a uncertain picture. While early profits were impressive, the end of patents and the appearance of cheaper alternatives have diminished sales. Thus, a thorough evaluation of present financi